Search results
Opinion: Putin’s lightning assault jolts Europe awake
CNN via Yahoo News· 2 hours agoWhile Putin was all smiles during his meeting with Xi in Beijing, Europe had reason to feel gloomy...
A Record $3.9 Billion Haul For The World’s 50 Highest-Paid Athletes
Forbes· 13 hours agoThe 50 highest-paid athletes in the world set a record for earnings for the fourth consecutive year,...
'Jeopardy! Masters' Night Six: Amy Schneider Squeaks Through to Semifinals Despite Triple Stumper
TV Insider· 18 hours agoMasters Season 2, there were a couple of foregone conclusions: Victoria Groce (with 13 match points)...
Novo Nordisk remains the most well-held European stock: Morgan Stanley By Investing.com
Investing.com· 8 hours agoNovo Nordisk remains the most well-held European stock: Morgan Stanley
Suri Cruise allegedly adopts new name for school musical's playbill
Newsweek· 20 hours agoAccording to a report from Hello Magazine, Suri played the role of Philoclea, and was supported in...
Here’s A Full Breakdown Of The Conspiracy Theory That Avril Lavigne Secretly Died In 2003 And Was...
BuzzFeed News via Yahoo News· 4 hours agoThis theory dates back to 2005, but it first gained traction in 2011 thanks to a Brazilian blog...
Wider Yachts Is Debuting a 92-Foot Hybrid Catamaran at the Venice Boat Show—Here’s a First Look
Robb Report via Yahoo News· 2 hours agoAt the stern, the tender garage can transform into a spacious aft beach club with fold-down bulwarks...
Which Side Should I Sleep on with an Eardrum Rupture?
Soundly via AOL· 19 hours agoDoes an eardrum rupture cause pain? An ear infection leading to an eardrum rupture can indeed be...
Two Stocks' Meme Rallies Absolutely Blow Away GameStop
Investor's Business Daily· 1 day agoThey're up 518.7% and 412%, respectively this week. Interestingly, neither stock is one caught up in...
Q1 2024 Omeros Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 hours agoMarket research to date has demonstrated a consistently favorable response to OMS906 among physicians, driven by the drug's data-based expected efficacy and low treatment burden. Interestingly ...
